Clinical Trial Update: Efficacy of Adaptogens in Patients With Long COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating adaptogens for long COVID-19; completed status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Adaptogens (unspecified)

Snippet

Sponsor: Swedish Herbal Institute AB | Conditions: Covid19 | Phase 2, Phase 3 | Status: COMPLETED